M. J. Avison, A. Nath, R. Greene-avison, F. A. Schmitt, R. N. Greenberg et al., Neuroimaging correlates of HIV-associated BBB compromise, Journal of Neuroimmunology, vol.157, issue.1-2, pp.140-146, 2004.
DOI : 10.1016/j.jneuroim.2004.08.025

F. Bussereau, M. Picard, J. Blancou, and P. Sureau, Treatment of rabies in mice and foxes with antiviral compounds, Acta. Virol, vol.32, pp.33-49, 1988.

P. G. Canonico, M. Kende, B. J. Luscri, and J. W. Huggins, In-vivo activity of antivirals against exotic RNA viral infections, Journal of Antimicrobial Chemotherapy, vol.14, issue.suppl A, pp.27-41, 1984.
DOI : 10.1093/jac/14.suppl_A.27

J. M. Crance, N. Scaramozzino, A. Jouan, and D. Garin, Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses, Antiviral Research, vol.58, issue.1, pp.73-79, 2003.
DOI : 10.1016/S0166-3542(02)00185-7

C. W. Day, D. F. Smee, J. G. Julander, V. F. Yamshchikov, R. W. Sidwell et al., Error-prone replication of West Nile virus caused by ribavirin, Antiviral Research, vol.67, issue.1, pp.38-45, 2005.
DOI : 10.1016/j.antiviral.2005.04.002

E. A. Ferrara, J. S. Oishi, R. W. Wannemacher, . Jr, and E. L. Stephen, Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys., Antimicrobial Agents and Chemotherapy, vol.19, issue.6, pp.1042-1049, 1981.
DOI : 10.1128/AAC.19.6.1042

B. E. Gilbert and P. R. Wyde, Pharmacokinetics of ribavirin aerosol in mice., Antimicrobial Agents and Chemotherapy, vol.32, issue.1, 1988.
DOI : 10.1128/AAC.32.1.117

B. E. Gilbert, P. R. Wyde, S. Z. Wilson, and R. K. Robins, Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of 143, 1991.

N. Grancher, F. Kedzierewicz, V. Venard, A. Marsura, C. Finance et al., Physicochemical Study of Ribavirin Complexes with ??-, ??- and ??-Cyclodextrins, Journal of Inclusion Phenomena, vol.38, issue.2, pp.149-157, 2005.
DOI : 10.1128/AAC.33.3.311

N. Grancher, V. Venard, F. Kedzierewicz, W. Ammerlaan, C. Finance et al., Improved antiviral activity in vitro of ribavirin against measles virus after complexation with cyclodextrins, Antiviral Research, vol.62, issue.3, pp.135-137, 2004.
DOI : 10.1016/j.antiviral.2004.01.003

M. Homma, A. L. Jayewardene, J. Gambertoglio, and F. Aweeka, High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes, Antimicrob. Agents Chemother, vol.43, pp.2716-2719, 1999.

Y. Honda, M. Hosoya, T. Ishii, S. Shigeta, and H. Suzuki, Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters., Antimicrobial Agents and Chemotherapy, vol.38, issue.4, pp.653-655, 1994.
DOI : 10.1128/AAC.38.4.653

M. Hosoya, S. Mori, A. Tomoda, K. Mori, Y. Sawaishi et al., Pharmacokinetics and Effects of Ribavirin following Intraventricular Administration for Treatment of Subacute Sclerosing Panencephalitis, Antimicrobial Agents and Chemotherapy, vol.48, issue.12, 2004.
DOI : 10.1128/AAC.48.12.4631-4635.2004

H. Jeulin, N. Grancher, F. Kedzierewicz, C. Finance, L. Faou et al., In vivo antiviral activity of ribavirin/alpha-cyclodextrin complex: Evaluation on experimental measles virus encephalitis in mice, International Journal of Pharmaceutics, vol.357, issue.1-2, pp.148-153, 2008.
DOI : 10.1016/j.ijpharm.2008.01.043

H. Jeulin, N. Grancher, F. Kedzierewicz, L. Faou, A. E. Venard et al., Evaluation by??Q-RTPCR of??the??efficacy of??ribavirin complexed with beta-cyclodextrin against??measles virus in??a??mouse encephalitis model, Pathologie Biologie, vol.54, issue.10, pp.541-544, 2006.
DOI : 10.1016/j.patbio.2006.07.008

T. Loftsson and M. E. Brewster, Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization, Journal of Pharmaceutical Sciences, vol.85, issue.10, pp.1017-1025, 1996.
DOI : 10.1021/js950534b

T. Loftsson and D. Duchene, Cyclodextrins and their pharmaceutical applications, International Journal of Pharmaceutics, vol.329, issue.1-2, pp.1-11, 2007.
DOI : 10.1016/j.ijpharm.2006.10.044

T. Loftsson, S. B. Vogensen, M. E. Brewster, and F. Konradsdottir, Effects of Cyclodextrins on Drug Delivery Through Biological Membranes, Journal of Pharmaceutical Sciences, vol.96, issue.10, pp.2532-2546, 2007.
DOI : 10.1002/jps.20992

V. Monnaert, D. Betbeder, L. Fenart, H. Bricout, A. M. Lenfant et al., Effects of ??- and Hydroxypropyl-??-cyclodextrins on the Transport of Doxorubicin across an in Vitro Model of Blood-Brain Barrier, Journal of Pharmacology and Experimental Therapeutics, vol.311, issue.3, pp.1115-1120, 2004.
DOI : 10.1124/jpet.104.071845

URL : https://hal.archives-ouvertes.fr/hal-00540903

V. Monnaert, S. Tilloy, H. Bricout, L. Fenart, R. Cecchelli et al., Behavior of ??-, ??-, and ??-Cyclodextrins and Their Derivatives on an in Vitro Model of Blood-Brain Barrier, Journal of Pharmacology and Experimental Therapeutics, vol.310, issue.2, pp.745-751, 2004.
DOI : 10.1124/jpet.104.067512

URL : https://hal.archives-ouvertes.fr/hal-00537883

Y. Persidsky, S. H. Ramirez, J. Haorah, and G. D. Kanmogne, Blood???brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions, Journal of Neuroimmune Pharmacology, vol.28, issue.Suppl 1, 2006.
DOI : 10.4049/jimmunol.167.4.2323

R. W. Sidwell, L. B. Allen, G. P. Khare, J. H. Huffman, J. T. Witkowski et al., Effect of 1-??-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Herpes and Vaccinia Keratitis and Encephalitis in Laboratory Animals, Antimicrobial Agents and Chemotherapy, vol.3, issue.2, pp.242-246, 1973.
DOI : 10.1128/AAC.3.2.242

M. S. Stoll and E. F. Hounsell, Selective purification of reduced oligosaccharides using a phenylboronic acid bond elut column: Potential application in HPLC, mass spectrometry, reductive amination procedures and antigenic/serum analysis, Biomedical Chromatography, vol.141, issue.6, 1988.
DOI : 10.1042/bst0120607

S. Tilloy, V. Monnaert, L. Fenart, H. Bricout, R. Cecchelli et al., Methylated ??-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood???brain barrier, Bioorganic & Medicinal Chemistry Letters, vol.16, issue.8, pp.2154-2157, 2006.
DOI : 10.1016/j.bmcl.2006.01.049

URL : https://hal.archives-ouvertes.fr/hal-00543357

K. Uekama and M. Otagiri, Cyclodextrin Drug Carrier Systems, Chemical Reviews, vol.98, issue.5, pp.1-40, 1987.
DOI : 10.1021/cr970025p

P. R. Wyde, D. K. Moore-poveda, E. De-clercq, J. Neyts, A. Matsuda et al., Use of Cotton Rats to Evaluate the Efficacy of Antivirals in Treatment of Measles Virus Infections, Antimicrobial Agents and Chemotherapy, vol.44, issue.5, pp.1146-1152, 2000.
DOI : 10.1128/AAC.44.5.1146-1152.2000

G. Wyshak and K. Detre, Estimating the number of organisms in quantal assays, Appl. Microbiol, vol.23, pp.784-790, 1972.

. Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects: two prospective, multicentre, open-label, parallel-group volunteer studies, Clin Drug Investig, vol.28, pp.409-420

H. Agut, Infections du système nerveux central, pp.627-630, 2003.

A. V. Albright, S. S. Soldan, and F. Gonzalez-scarano, Pathogenesis of Human Immunodeficiency Virus-Induced Neurological Disease, Journal of Neurovirology, vol.9, issue.2, pp.222-227, 2003.
DOI : 10.1080/13550280390194073

S. Alenius, Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds, Archives of Virology, vol.297, issue.2, pp.149-156, 1980.
DOI : 10.1002/cber.19240570625

Z. Ambrose, L. Compton, M. Piatak, . Jr, D. Lu et al., Incomplete Protection against Simian Immunodeficiency Virus Vaginal Transmission in Rhesus Macaques by a Topical Antiviral Agent Revealed by Repeat Challenges, Journal of Virology, vol.82, issue.13, pp.6591-6599, 2008.
DOI : 10.1128/JVI.02730-07

G. Andrei, R. Snoeck, M. Vandeputte, and E. De-clercq, Activities of various compounds against murine and primate polyomaviruses, Antimicrob Agents Chemother, vol.41, pp.587-593, 1997.

J. R. Arribas, G. A. Storch, D. B. Clifford, and A. C. Tselis, Cytomegalovirus Encephalitis, Annals of Internal Medicine, vol.125, issue.7, pp.577-587, 1996.
DOI : 10.7326/0003-4819-125-7-199610010-00008

P. Asaria and E. Macmahon, Measles in the United Kingdom: can we eradicate it by 2010?, BMJ, vol.333, issue.7574, pp.890-895, 2006.
DOI : 10.1136/bmj.38989.445845.7C

D. L. Barnard, Inhibitors of Measles Virus, Antiviral Chemistry and Chemotherapy, vol.30, issue.3, pp.111-119, 2004.
DOI : 10.1007/s10072-003-0147-6

P. Barzo, A. Marmarou, P. Fatouros, F. Corwin, and J. Dunbar, Magnetic resonance imaging???monitored acute blood-brain barrier changes in experimental traumatic brain injury, Journal of Neurosurgery, vol.60, issue.6, pp.1113-1121, 1996.
DOI : 10.1016/0006-8993(85)91611-7

J. Beigel and M. Bray, Current and future antiviral therapy of severe seasonal and avian influenza, Antiviral Research, vol.78, issue.1, pp.91-102, 2008.
DOI : 10.1016/j.antiviral.2008.01.003

P. Blasi, S. Giovagnoli, A. Schoubben, M. Ricci, and C. Rossi, Solid lipid nanoparticles for targeted brain drug delivery???, Advanced Drug Delivery Reviews, vol.59, issue.6, pp.454-477, 2007.
DOI : 10.1016/j.addr.2007.04.011

M. E. Brewster and T. Loftsson, Cyclodextrins as pharmaceutical solubilizers, Advanced Drug Delivery Reviews, vol.59, issue.7, pp.645-666, 2007.
DOI : 10.1016/j.addr.2007.05.012

F. Bussereau, M. Picard, J. Blancou, and P. Sureau, Treatment of rabies in mice and foxes with antiviral compounds, Acta. Virol, vol.32, pp.33-49, 1988.

P. G. Canonico, M. Kende, B. J. Luscri, and J. W. Huggins, In-vivo activity of antivirals against exotic RNA viral infections, Journal of Antimicrobial Chemotherapy, vol.14, issue.suppl A, pp.27-41, 1984.
DOI : 10.1093/jac/14.suppl_A.27

D. R. Carrigan, Adenovirus Infections in Immunocompromised Patients, The American Journal of Medicine, vol.102, issue.3, pp.71-74, 1997.
DOI : 10.1016/S0002-9343(97)00015-6

P. M. Carvey, C. H. Zhao, B. Hendey, H. Lum, J. Trachtenberg et al., 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability, European Journal of Neuroscience, vol.128, issue.Suppl. 1, pp.1158-1168, 2005.
DOI : 10.1099/0022-1317-50-9-812

S. Casolari, E. Briganti, M. Zanotti, T. Zauli, L. Nicoletti et al., A fatal case of encephalitis associated with Chikungunya virus infection, Scandinavian Journal of Infectious Diseases, vol.69, issue.11-12, pp.1-2, 2008.
DOI : 10.1212/01.wnl.0000277267.07220.88

R. Cattaneo, A. Schmid, D. Eschle, K. Baczko, V. Ter-meulen et al., Biased hypermutation and other genetic changes in defective measles viruses in human brain infections, Cell, vol.55, issue.2, pp.255-265, 1988.
DOI : 10.1016/0092-8674(88)90048-7

R. Cecchelli, B. Dehouck, L. Descamps, L. Fenart, V. Buee-scherrer et al., In vitro model for evaluating drug transport across the blood???brain barrier, vitro model for evaluating drug transport across the blood-brain barrier, pp.165-178, 1999.
DOI : 10.1016/S0169-409X(98)00083-0

URL : https://hal.archives-ouvertes.fr/hal-00534832

M. S. Chadha, J. A. Comer, L. Lowe, P. A. Rota, P. E. Rollin et al., Nipah virus-associated encephalitis outbreak, Emerg Infect Dis, vol.12, 2006.

M. D. Chavanpatil and P. R. Vavia, The influence of absorption enhancers on nasal absorption of acyclovir, European Journal of Pharmaceutics and Biopharmaceutics, vol.57, issue.3, pp.483-487, 2004.
DOI : 10.1016/j.ejpb.2004.01.001

J. M. Crance, N. Scaramozzino, A. Jouan, and D. Garin, Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses, Antiviral Research, vol.58, issue.1, pp.73-79, 2003.
DOI : 10.1016/S0166-3542(02)00185-7

S. Crotty and R. Andino, Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin, Microbes and Infection, vol.4, issue.13, pp.1301-1307, 2002.
DOI : 10.1016/S1286-4579(02)00008-4

S. Crotty, D. Maag, J. J. Arnold, W. Zhong, J. Y. Lau et al., The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen, Nature Medicine, vol.13, issue.12, pp.1375-1379, 2000.
DOI : 10.1021/bi00706a014

C. Crumpacker, G. Bubley, D. Lucey, S. Hussey, and J. Connor, RIBAVIRIN ENTERS CEREBROSPINAL FLUID, The Lancet, vol.328, issue.8497, pp.45-46, 1986.
DOI : 10.1016/S0140-6736(86)92590-0

L. E. Davis, J. D. Beckham, and K. L. Tyler, North American Encephalitic Arboviruses, Neurologic Clinics, vol.26, issue.3, pp.727-757, 2008.
DOI : 10.1016/j.ncl.2008.03.012

A. G. De-boer and P. J. Gaillard, Drug Targeting to the Brain, Annual Review of Pharmacology and Toxicology, vol.47, issue.1, pp.323-355, 2007.
DOI : 10.1146/annurev.pharmtox.47.120505.105237

A. G. De-boer and P. J. Gaillard, Strategies to Improve Drug Delivery Across the Blood-Brain Barrier, Clinical Pharmacokinetics, vol.93, issue.9, pp.553-576, 2007.
DOI : 10.1016/0304-3940(96)12850-0

D. Clercq, E. Luczak, M. Shugar, D. Torrence, P. F. Waters et al., Effect of Cytosine Arabinoside, lododeoxyuridine, Ethyldeoxyuridine, Thiocyanatodeoxyuridine, and Ribavirin on Tail Lesion Formation in Mice Infected with Vaccinia Virus, Experimental Biology and Medicine, vol.151, issue.3, pp.487-490, 1976.
DOI : 10.3181/00379727-151-39241

J. Defaye, J. M. Garcia-fernandez, and C. Ortiz-mellet, Les cyclodextrines en pharmacie : perspectives pour le ciblage d???actifs th??rapeutiques et le contr??le d???interactions membranaires, Annales Pharmaceutiques Fran??aises, vol.65, issue.1, pp.33-49, 2007.
DOI : 10.1016/S0003-4509(07)90015-2

D. Valle and E. M. , Cyclodextrins and their uses: a review, Process Biochemistry, vol.39, issue.9, pp.1033-1046, 2004.
DOI : 10.1016/S0032-9592(03)00258-9

J. A. Desjardin and D. R. Snydman, Antiviral Immunotherapy, BioDrugs, vol.9, issue.6, 1998.
DOI : 10.2165/00063030-199809060-00006

P. Devaux and R. Cattaneo, Measles Virus Phosphoprotein Gene Products: Conformational Flexibility of the P/V Protein Amino-Terminal Domain and C Protein Infectivity Factor Function, Journal of Virology, vol.78, issue.21, pp.11632-11640, 2004.
DOI : 10.1128/JVI.78.21.11632-11640.2004

D. Stefano, G. Colonna, F. P. Bongini, A. Busi, C. Mattioli et al., Ribavirin conjugated with lactosaminated poly-l-lysine, Biochemical Pharmacology, vol.54, issue.3, pp.357-363, 1997.
DOI : 10.1016/S0006-2952(97)00223-2

E. R. Dubberke, B. Tu, D. J. Rivet, G. A. Storch, A. Apisarnthanarak et al., Acute meningoencephalitis caused by adenovirus serotype 26, Journal of Neurovirology, vol.12, issue.3, pp.235-240, 2006.
DOI : 10.1080/13550280600846633

J. Duclos-vallée and D. Samuel, La ribavirine, Médecine thérapeutique, pp.53-57, 2001.

T. Duke and C. S. Mgone, Measles: not just another viral exanthem, The Lancet, vol.361, issue.9359, pp.763-773, 2003.
DOI : 10.1016/S0140-6736(03)12661-X

W. P. Duprex, I. Duffy, S. Mcquaid, L. Hamill, S. L. Cosby et al., The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain, J Virol, vol.73, pp.6916-6922, 1999.

A. H. El-kamel, A. A. Abdel-aziz, A. J. Fatani, and H. I. El-subbagh, Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: Synthesis, in vitro and in vivo assessment, International Journal of Pharmaceutics, vol.358, issue.1-2, pp.248-255, 2008.
DOI : 10.1016/j.ijpharm.2008.04.021

J. R. Ewing, R. A. Knight, T. N. Nagaraja, J. S. Yee, V. Nagesh et al., Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of14C-sucrose in areas of blood-brain opening, Magnetic Resonance in Medicine, vol.19, issue.2, pp.283-292, 2003.
DOI : 10.1016/S0166-2236(98)01261-2

C. Fang, P. Srivastava, and C. C. Lin, Effect of ribavirin, levovirin and viramidine on liver toxicological gene expression in rats, Journal of Applied Toxicology, vol.261, issue.6, pp.453-459, 2003.
DOI : 10.1073/pnas.111126298

E. A. Ferrara, J. S. Oishi, R. W. Wannemacher, . Jr, and E. L. Stephen, Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys., Antimicrobial Agents and Chemotherapy, vol.19, issue.6, pp.1042-1049, 1981.
DOI : 10.1128/AAC.19.6.1042

L. Fiume, D. Stefano, G. Busi, C. Incitti, F. Rapicetta et al., Coupling to lactosaminated poly-L-lysine reduces the toxic effects of ribavirin on red blood cells, Journal of Hepatology, vol.29, issue.6, pp.1032-1033, 1998.
DOI : 10.1016/S0168-8278(98)80137-2

A. L. Forni, N. W. Schluger, and R. B. Roberts, Severe Measles Pneumonitis in Adults: Evaluation of Clinical Characteristics and Therapy with Intravenous Ribavirin, Clinical Infectious Diseases, vol.19, issue.3, pp.454-462, 1994.
DOI : 10.1093/clinids/19.3.454

D. W. Frank, J. E. Gray, and R. N. Weaver, Cyclodextrin nephrosis in the rat, Am J Pathol, vol.83, pp.367-382, 1976.

B. Frederic, L. S. Malika, H. Marie, M. Eric, A. Philippe et al., Percutaneous Absorption of Metopimazine and Effect of Cyclodextrins, Drug Development and Industrial Pharmacy, vol.19, issue.5, pp.478-484, 2008.
DOI : 10.3109/10837459809009856

F. Freymuth, Paramyxoviridae, pp.459-480, 2003.

M. W. Gaber, H. Yuan, J. T. Killmar, M. D. Naimark, M. F. Kiani et al., An intravital microscopy study of radiation-induced changes in permeability and leukocyte???endothelial cell interactions in the microvessels of the rat pia mater and cremaster muscle, Brain Research Protocols, vol.13, issue.1, pp.1-10, 2004.
DOI : 10.1016/j.brainresprot.2003.11.005

N. Garmashova, S. Atasheva, W. Kang, S. C. Weaver, E. Frolova et al., Analysis of Venezuelan Equine Encephalitis Virus Capsid Protein Function in the Inhibition of Cellular Transcription, Journal of Virology, vol.81, issue.24, pp.13552-13565, 2007.
DOI : 10.1128/JVI.01576-07

B. E. Gilbert, S. Z. Wilson, V. Knight, R. B. Couch, J. M. Quarles et al., Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria, Antimicrob Agents Chemother, vol.78384, issue.27, pp.309-313, 1985.

B. E. Gilbert and P. R. Wyde, Pharmacokinetics of ribavirin aerosol in mice., Antimicrobial Agents and Chemotherapy, vol.32, issue.1, pp.117-121, 1988.
DOI : 10.1128/AAC.32.1.117

B. E. Gilbert, P. R. Wyde, S. Z. Wilson, and R. K. Robins, Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus., Antimicrobial Agents and Chemotherapy, vol.35, issue.7, pp.1448-1453, 1991.
DOI : 10.1128/AAC.35.7.1448

C. A. Glaser, S. Honarmand, L. J. Anderson, D. P. Schnurr, B. Forghani et al., Beyond Viruses: Clinical Profiles and Etiologies Associated with Encephalitis, Clinical Infectious Diseases, vol.17, issue.4, pp.1565-1577, 2006.
DOI : 10.1128/CMR.17.4.903-925.2004

P. Glue, The clinical pharmacology of ribavirin, Semin Liver Dis, vol.19, pp.17-24, 1999.

M. Segura and G. Velasco-gallegos, Comparison of the stability, efficacy, and adverse effect profile of the innovator 0.005% latanoprost ophthalmic solution and a novel cyclodextrincontaining formulation, J Clin Pharmacol, vol.47, pp.121-126, 2007.

J. D. Graci and C. E. Cameron, Mechanisms of action of ribavirin against distinct viruses, Reviews in Medical Virology, vol.100, issue.1, pp.37-48, 2006.
DOI : 10.1093/infdis/164.6.1119

N. Grancher, Vectorisation de la ribavirine par les cyclodextrines : Caractérisation physico-chimique des complexes et activité antivirale in vitro et in vivo sur le virus de la rougeole, Ecole doctorale "Biologie, santé et environnement, p.198, 2005.

N. Grancher, V. Venard, F. Kedzierewicz, W. Ammerlaan, C. Finance et al., Improved antiviral activity in vitro of ribavirin against measles virus after complexation with cyclodextrins, Antiviral Research, vol.62, issue.3, pp.135-137, 2004.
DOI : 10.1016/j.antiviral.2004.01.003

D. E. Griffin, Measles Virus, pp.1267-1312, 1995.
DOI : 10.3201/eid0401.980105

D. E. Griffin, Encephalitis, myelitis, and neuritis. In: Mandell, Douglas, and Bennett's principles and practice of infectious diseases, J.E. Bennett & R. Dolin), vol.1, p.pp, 2000.

W. H. Haas, T. Breuer, G. Pfaff, H. Schmitz, P. Kohler et al., Imported Lassa Fever in Germany: Surveillance and Management of Contact Persons, Clinical Infectious Diseases, vol.4, issue.10, pp.1254-1258, 2003.
DOI : 10.1016/S0149-2918(00)90004-3

N. A. Halsey, Measles in developing countries, BMJ, vol.333, issue.7581, 1234.
DOI : 10.1136/bmj.39058.361620.BE

B. T. Hawkins and R. D. Egleton, Pathophysiology of the Blood???Brain Barrier: Animal Models and Methods, Curr Top Dev Biol, vol.80, pp.277-309, 2008.
DOI : 10.1016/S0070-2153(07)80007-X

B. T. Hawkins, T. F. Lundeen, K. M. Norwood, H. L. Brooks, and R. D. Egleton, Increased blood???brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases, Diabetologia, vol.36, issue.Pt 23, pp.202-211, 2007.
DOI : 10.1152/ajpheart.00027.2002

T. Higuchi and K. A. Connors, Phase solubility techniques, Advances in Analytical Chemistry and Instrumentation, pp.117-212, 1965.

M. R. Holbrook and B. B. Gowen, Animal models of highly pathogenic RNA viral infections: Encephalitis viruses, Antiviral Research, vol.78, issue.1, pp.69-78, 2008.
DOI : 10.1016/j.antiviral.2007.10.004

M. Homma, A. L. Jayewardene, J. Gambertoglio, and F. Aweeka, High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes, 1999.

Y. Honda, M. Hosoya, T. Ishii, S. Shigeta, and H. Suzuki, Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters., Antimicrobial Agents and Chemotherapy, vol.38, issue.4, pp.653-655, 1994.
DOI : 10.1128/AAC.38.4.653

P. Hooper, S. Zaki, P. Daniels, and D. Middleton, Comparative pathology of the diseases caused by Hendra and Nipah viruses, Microbes and Infection, vol.3, issue.4, pp.315-322, 2001.
DOI : 10.1016/S1286-4579(01)01385-5

S. M. Horikami and S. A. Moyer, Structure, Transcription, and Replication of Measles Virus, Curr Top Microbiol Immunol, vol.191, pp.35-50, 1995.
DOI : 10.1007/978-3-642-78621-1_3

M. Hosoya, S. Mori, A. Tomoda, K. Mori, Y. Sawaishi et al., Pharmacokinetics and Effects of Ribavirin following Intraventricular Administration for Treatment of Subacute Sclerosing Panencephalitis, Antimicrobial Agents and Chemotherapy, vol.48, issue.12, pp.4631-4635, 2004.
DOI : 10.1128/AAC.48.12.4631-4635.2004

M. Hosoya, S. Shigeta, S. Mori, A. Tomoda, S. Shiraishi et al., High-Dose Intravenous Ribavirin Therapy for Subacute Sclerosing Panencephalitis, Antimicrobial Agents and Chemotherapy, vol.45, issue.3, pp.943-945, 2001.
DOI : 10.1128/AAC.45.3.943-945.2001

L. Hovgaard and H. Brondsted, Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins, Pharmaceutical Research, vol.12, issue.9, pp.1328-1332, 1995.
DOI : 10.1023/A:1016225707807

P. Huang, W. Xu, S. I. Yoon, C. Chen, P. L. Chong et al., Cholesterol reduction by methyl-??-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells, Biochemical Pharmacology, vol.73, issue.4, pp.534-549, 2007.
DOI : 10.1016/j.bcp.2006.10.032

J. D. Huber, R. L. Vangilder, and K. A. Houser, Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats, American Journal of Physiology-Heart and Circulatory Physiology, vol.291, issue.6, pp.2660-2668, 2006.
DOI : 10.1111/j.1471-4159.1986.tb01760.x

J. H. Huffman, R. W. Sidwell, G. P. Khare, J. T. Witkowski, L. B. Allen et al., In Vitro Effect of 1-??-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Deoxyribonucleic Acid and Ribonucleic Acid Viruses, Antimicrobial Agents and Chemotherapy, vol.3, issue.2, pp.235-241, 1973.
DOI : 10.1128/AAC.3.2.235

Y. Huiming, W. Chaomin, and M. Meng, Vitamin A for treating measles in children, 2005.
DOI : 10.1596/0-1952-0890-0

. Invs, Calendrier vaccinal 2008 -Avis du Haut conseil de la santé publique, Bulletin Epidémiologique Hebdomadaire, vol.133, pp.26-43, 2008.

T. Irie, S. Kuwahara, M. Otagiri, K. Uekama, and T. Iwamasa, Reduction in the local tissue toxicity of chlorpromazine by .BETA.-cyclodextrin complexation., Journal of Pharmacobio-Dynamics, vol.6, issue.10, pp.790-792, 1983.
DOI : 10.1248/bpb1978.6.790

T. Irie and K. Uekama, Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation, Journal of Pharmaceutical Sciences, vol.86, issue.2, pp.147-162, 1997.
DOI : 10.1021/js960213f

T. Ishii, M. Hosoya, S. Mori, S. Shigeta, and H. Suzuki, Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis, Antimicrob Agents Chemother, vol.40, pp.241-243, 1996.

M. Jalalipour, A. R. Najafabadi, K. Gilani, H. Esmaily, and H. Tajerzadeh, Effect of dimethylbeta-cyclodextrin concentrations on the pulmonary delivery of recombinant human growth hormone dry powder in rats, J Pharm Sci, 2008.

H. Jeulin, N. Grancher, F. Kedzierewicz, C. Finance, L. Faou et al., In vivo antiviral activity of ribavirin/alpha-cyclodextrin complex: Evaluation on experimental measles virus encephalitis in mice, International Journal of Pharmaceutics, vol.357, issue.1-2, pp.148-153, 2008.
DOI : 10.1016/j.ijpharm.2008.01.043

H. Jeulin, N. Grancher, F. Kedzierewicz, L. Faou, A. E. Venard et al., Evaluation by??Q-RTPCR of??the??efficacy of??ribavirin complexed with beta-cyclodextrin against??measles virus in??a??mouse encephalitis model, Pathologie Biologie, vol.54, issue.10, pp.541-544, 2006.
DOI : 10.1016/j.patbio.2006.07.008

M. Juhler, D. I. Barry, H. Offner, G. Konat, L. Klinken et al., Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat, Brain Research, vol.302, issue.2, pp.347-355, 1984.
DOI : 10.1016/0006-8993(84)90249-X

P. Kamberi, R. A. Sobel, K. V. Clemons, A. Waldvogel, J. M. Striebel et al., Comparison of Itraconazole and Fluconazole Treatments in a Murine Model of Coccidioidal Meningitis, Antimicrobial Agents and Chemotherapy, vol.51, issue.3, pp.998-1003, 2007.
DOI : 10.1128/AAC.00332-06

S. A. Khan, K. S. Patil, and P. G. Yeole, Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies, Pharmazie, vol.63, pp.348-351, 2008.

J. C. Kim and M. D. Kim, After-rinsing hair growth promotion of minoxidil-containing amino alpha-cyclodextrins, J Microbiol Biotechnol, vol.17, pp.1965-1969, 2007.

C. Kishimoto, C. S. Crumpacker, and W. H. Abelmann, Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets, J Am Coll Cardiol, vol.12, 1988.

B. K. Kleinschmidt-demasters and D. H. Gilden, The Expanding Spectrum of Herpesvirus Infections of the Nervous System, Brain Pathology, vol.22, issue.5, pp.440-451, 2001.
DOI : 10.1016/S0387-7604(00)00113-3

R. A. Knight, T. N. Nagaraja, J. R. Ewing, V. Nagesh, P. A. Whitton et al., Quantitation and localization of blood-to-brain influx by magnetic resonance imaging and quantitative autoradiography in a model of transient focal ischemia, Magnetic Resonance in Medicine, vol.64, issue.4, pp.813-821, 2005.
DOI : 10.1161/01.HYP.21.1.105

J. R. Kremer, K. E. Brown, L. Jin, S. Santibanez, S. V. Shulga et al., High Genetic Diversity of Measles Virus, World Health Organization European Region, 2005???2006, High genetic diversity of measles virus, World Health Organization European Region, pp.107-114, 2005.
DOI : 10.3201/eid1401.070778

U. Kunze, Fr??hsommer-Meningo-Enzephalitis: ein europ??isches Gesundheitsproblem, Wiener Medizinische Wochenschrift, vol.3, issue.11-12, pp.376-378, 2006.
DOI : 10.2310/7060.2004.19107

Y. C. Kuo and F. L. Su, Transport of stavudine, delavirdine, and saquinavir across the blood???brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles, International Journal of Pharmaceutics, vol.340, issue.1-2, pp.143-152, 2007.
DOI : 10.1016/j.ijpharm.2007.03.012

K. K. Lau, S. T. Lai, J. Y. Lai, W. W. Yan, T. M. So et al., Acute encephalitis complicating rubella, Hong Kong Med J, vol.4, pp.325-328, 1998.

T. R. Leahy, D. W. Webb, H. Hoey, and K. M. Butler, VARICELLA ZOSTER VIRUS ASSOCIATED ACUTE ASEPTIC MENINGITIS WITHOUT EXANTHEM IN AN IMMUNOCOMPETENT 14-YEAR-OLD BOY, The Pediatric Infectious Disease Journal, vol.27, issue.4, pp.362-363, 2008.
DOI : 10.1097/INF.0b013e318160ee11

S. H. Lee, Y. H. Kim, H. J. Yu, N. S. Cho, T. H. Kim et al., Enhanced Bioavailability of Soy Isoflavones by Complexation with ??-Cyclodextrin in Rats, Bioscience, Biotechnology, and Biochemistry, vol.133, issue.2, pp.2927-2933, 2007.
DOI : 10.1267/ahc.06024

L. Lenaerts and L. Naesens, Antiviral therapy for adenovirus infections, Antiviral Research, vol.71, issue.2-3, pp.172-180, 2006.
DOI : 10.1016/j.antiviral.2006.04.007

F. Li, L. Hong, C. I. Mau, R. Chan, T. Hendricks et al., Transport of levovirin prodrugs in the human intestinal Caco-2 cell line, Journal of Pharmaceutical Sciences, vol.95, issue.6, pp.1318-1325, 2006.
DOI : 10.1002/jps.20434

U. G. Liebert, K. Baczko, H. Budka, and V. Ter-meulen, Restricted Expression of Measles Virus Proteins in Brains from Cases of Subacute Sclerosing Panencephalitis, Journal of General Virology, vol.67, issue.11, pp.2435-2444, 1986.
DOI : 10.1099/0022-1317-67-11-2435

C. C. Lin, D. Lourenco, G. Xu, and L. T. Yeh, Disposition and Metabolic Profiles of [14C]Viramidine and [14C]Ribavirin in Rat and Monkey Red Blood Cells and Liver, Antimicrobial Agents and Chemotherapy, vol.48, issue.5, pp.1872-1875, 2004.
DOI : 10.1128/AAC.48.5.1872-1875.2004

C. C. Lin, C. Xu, N. Zhu, and L. T. Yeh, Absorption, Metabolism, and Excretion of [14C]Viramidine in Humans, Antimicrobial Agents and Chemotherapy, vol.50, issue.7, pp.2368-2373, 2006.
DOI : 10.1128/AAC.00118-06

L. Lindquist and O. Vapalahti, Tick-borne encephalitis, The Lancet, vol.371, issue.9627, pp.1861-1871, 2008.
DOI : 10.1016/S0140-6736(08)60800-4

T. Loftsson and M. E. Brewster, Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization, Journal of Pharmaceutical Sciences, vol.85, issue.10, pp.1017-1025, 1996.
DOI : 10.1021/js950534b

T. Loftsson and D. Duchene, Cyclodextrins and their pharmaceutical applications, International Journal of Pharmaceutics, vol.329, issue.1-2, pp.1-11, 2007.
DOI : 10.1016/j.ijpharm.2006.10.044

T. Loftsson and E. Stefansson, Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye, Acta Ophthalmologica Scandinavica, vol.435, issue.2, pp.144-150, 2002.
DOI : 10.3109/02713689109001766

T. Loftsson, S. B. Vogensen, M. E. Brewster, and F. Konradsdottir, Effects of Cyclodextrins on Drug Delivery Through Biological Membranes, Journal of Pharmaceutical Sciences, vol.96, issue.10, pp.2532-2546, 2007.
DOI : 10.1002/jps.20992

C. Lohmann, S. Huwel, and H. J. Galla, Predicting Blood-Brain Barrier Permeability of Drugs: Evaluation of Different In Vitro Assays, Journal of Drug Targeting, vol.10, issue.4, pp.263-276, 2002.
DOI : 10.1080/10611860290031903

C. R. Magnussen, R. G. Douglas, . Jr, R. F. Betts, F. K. Roth et al., Double-Blind Evaluation of Oral Ribavirin (Virazole) in Experimental Influenza A Virus Infection in Volunteers, Antimicrobial Agents and Chemotherapy, vol.12, issue.4, 1977.
DOI : 10.1128/AAC.12.4.498

A. Mailles, Encéphalites infectieuses en France : Les données du PMSI. In: 25 e Réunion interdisciplinaire de chimiothérapie anti-infectieuse, 2005.

A. Mailles, J. P. Stahl, V. Vaillant, and C. Brouard, [Epidemiology, improvment of etiological diagnosis, and outcome of infectious encephalitis in France in 2007: preliminary results of a national prospective study, Med Mal Infect, vol.38, pp.25-38, 2008.

E. Masliah, R. M. Deteresa, M. E. Mallory, and L. A. Hansen, Changes in pathological findings at autopsy in AIDS cases for the last 15 years, AIDS, vol.14, issue.1, pp.69-74, 2000.
DOI : 10.1097/00002030-200001070-00008

J. R. Mazzeo and D. J. Krull, Immobilized boronates for the isolation and separation of bioanalytes, Biochromatography, vol.4, pp.124-130, 1989.

J. R. Mccammon and V. W. Riesser, Effects of Ribavirin on BHK-21 Cells Acutely or Persistently Infected With Mumps Virus, Antimicrobial Agents and Chemotherapy, vol.15, issue.3, pp.356-360, 1979.
DOI : 10.1128/AAC.15.3.356

P. L. Mccormack and L. J. Scott, Diclofenac???Sodium???Injection???(Dyloject??), Drugs, vol.80, issue.4B, pp.123-130, 2008.
DOI : 10.2165/00003495-200868010-00008

W. H. Mcneill, Plagues and People, Health Care Management Review, vol.2, issue.2, 1976.
DOI : 10.1097/00004010-197700220-00022

L. P. Mendoza, R. V. Bronzoni, O. M. Takayanagui, V. H. Aquino, and L. T. Figueiredo, Viral infections of the central nervous system in Brazil, Journal of Infection, vol.54, issue.6, pp.589-596, 2007.
DOI : 10.1016/j.jinf.2006.11.013

T. Minagawa, T. Sakuma, S. Kuwajima, T. K. Yamamoto, and H. Iida, Characterization of Measles Viruses in Establishment of Persistent Infections in Human Lymphoid Cell Line, Journal of General Virology, vol.33, issue.3, pp.361-379, 1976.
DOI : 10.1099/0022-1317-33-3-361

A. Mirand, C. Henquell, C. Archimbaud, M. Chambon, F. Charbonne et al., Prospective Identification of Enteroviruses Involved in Meningitis in 2006 through Direct Genotyping in Cerebrospinal Fluid, Journal of Clinical Microbiology, vol.46, issue.1, pp.87-96, 2008.
DOI : 10.1128/JCM.01020-07

M. Moayeri, T. M. Robinson, S. H. Leppla, and V. A. Karginov, In Vivo Efficacy of ??-Cyclodextrin Derivatives against Anthrax Lethal Toxin, Antimicrobial Agents and Chemotherapy, vol.52, issue.6, pp.2239-2241, 2008.
DOI : 10.1128/AAC.00009-08

K. Moeller, I. Duffy, P. Duprex, B. Rima, R. Beschorner et al., Recombinant Measles Viruses Expressing Altered Hemagglutinin (H) Genes: Functional Separation of Mutations Determining H Antibody Escape from Neurovirulence, Journal of Virology, vol.75, issue.16, pp.7612-7620, 2001.
DOI : 10.1128/JVI.75.16.7612-7620.2001

V. Monnaert, D. Betbeder, L. Fenart, H. Bricout, A. M. Lenfant et al., Effects of ??- and Hydroxypropyl-??-cyclodextrins on the Transport of Doxorubicin across an in Vitro Model of Blood-Brain Barrier, Journal of Pharmacology and Experimental Therapeutics, vol.311, issue.3, pp.1115-1120, 2004.
DOI : 10.1124/jpet.104.071845

URL : https://hal.archives-ouvertes.fr/hal-00540903

V. Monnaert, S. Tilloy, H. Bricout, L. Fenart, R. Cecchelli et al., Behavior of ??-, ??-, and ??-Cyclodextrins and Their Derivatives on an in Vitro Model of Blood-Brain Barrier, Journal of Pharmacology and Experimental Therapeutics, vol.310, issue.2, pp.745-751, 2004.
DOI : 10.1124/jpet.104.067512

URL : https://hal.archives-ouvertes.fr/hal-00537883

A. D. Mooradian, M. J. Haas, O. Batejko, M. Hovsepyan, and S. S. Feman, Statins Ameliorate Endothelial Barrier Permeability Changes in the Cerebral Tissue of Streptozotocin-Induced Diabetic Rats, Diabetes, vol.54, issue.10, pp.2977-2982, 2005.
DOI : 10.2337/diabetes.54.10.2977

C. P. Muller, J. R. Kremer, J. M. Best, I. Dourado, H. Triki et al., Reducing global disease burden of measles and rubella: Report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005, Vaccine, vol.25, issue.1, pp.1-9, 2005.
DOI : 10.1016/j.vaccine.2006.07.039

URL : https://hal.archives-ouvertes.fr/pasteur-01375237

B. A. Mungall, D. Middleton, G. Crameri, J. Bingham, K. Halpin et al., Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine, Journal of Virology, vol.80, issue.24, pp.12293-12302, 2006.
DOI : 10.1128/JVI.01619-06

I. C. Munro, P. M. Newberne, V. R. Young, and A. Bar, Safety assessment of ??-cyclodextrin, Regulatory Toxicology and Pharmacology, vol.39, pp.3-13, 2004.
DOI : 10.1016/j.yrtph.2004.05.008

Y. Murakami, T. Seya, M. Kurita, A. Fukui, S. Ueda et al., Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein???Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus, Biochemical Journal, vol.330, issue.3, pp.1351-1359, 1998.
DOI : 10.1042/bj3301351

F. A. Murphy and N. Nathanson, An atlas of viral pathogenesis, 1997.

L. Naesens, P. Bonnafous, H. Agut, and E. De-clercq, Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts, J Clin Virol, vol.37, 2006.

L. Naesens, L. Lenaerts, G. Andrei, R. Snoeck, D. Van-beers et al., Antiadenovirus Activities of Several Classes of Nucleoside and Nucleotide Analogues, Antimicrobial Agents and Chemotherapy, vol.49, issue.3, pp.1010-1016, 2005.
DOI : 10.1128/AAC.49.3.1010-1016.2005

L. P. Nagata, W. G. Hu, S. A. Masri, G. A. Rayner, F. L. Schmaltz et al., Efficacy of DNA vaccination against western equine encephalitis virus infection, Vaccine, vol.23, issue.17-18, pp.2280-2283, 2005.
DOI : 10.1016/j.vaccine.2005.01.032

S. S. Natah, A. Mouihate, Q. J. Pittman, and K. A. Sharkey, Disruption of the blood-brain barrier during TNBS colitis, Neurogastroenterology and Motility, vol.86, issue.4, pp.433-446, 2005.
DOI : 10.1038/sj.mn.7300152

P. A. Neighbour, B. Rager-zisman, and B. R. Bloom, Susceptibility of mice to acute and persistent measles infection, Infect. Immun, vol.21, pp.764-770, 1978.

C. Nicolazzi, V. Venard, L. Faou, A. Finance, and C. , In vitro antiviral efficacy of the ganciclovir complexed with ??-cyclodextrin on human cytomegalovirus clinical strains, Antiviral Research, vol.54, issue.2, pp.121-127, 2002.
DOI : 10.1016/S0166-3542(01)00218-2

S. Niewiesk, U. Brinckmann, B. Bankamp, S. Sirak, U. G. Liebert et al., Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes, J. Virol, vol.67, pp.75-81, 1993.

N. Nonaka, S. A. Farr, H. Kageyama, S. Shioda, and W. A. Banks, Delivery of Galanin-Like Peptide to the Brain: Targeting with Intranasal Delivery and Cyclodextrins, Journal of Pharmacology and Experimental Therapeutics, vol.325, issue.2, pp.513-519, 2008.
DOI : 10.1124/jpet.107.132381

E. Norrby, H. Sheshberadaran, K. C. Mccullough, W. C. Carpenter, and C. Orvell, Is Rinderpest Virus the Archevirus of the <i>Morbillivirus </i>Genus?, Intervirology, vol.23, issue.4, pp.228-232, 1985.
DOI : 10.1159/000149609

W. H. Oldendorf, Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard, Brain Research, vol.24, issue.2, pp.372-376, 1970.
DOI : 10.1016/0006-8993(70)90123-X

Y. Olsson, E. Svensjo, K. E. Arfors, and D. Hultstrom, Fluorescein labelled dextrans as tracers for vascular permeability studies in the nervous system, Acta Neuropathologica, vol.6, issue.1, pp.45-50, 1975.
DOI : 10.1007/BF00685963

W. M. Pardridge, Drug Targeting to the Brain, Pharmaceutical Research, vol.20, issue.9, pp.1733-1744, 2007.
DOI : 10.1161/01.STR.32.6.1378

Y. Persidsky, S. H. Ramirez, J. Haorah, and G. D. Kanmogne, Blood???brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions, Journal of Neuroimmune Pharmacology, vol.28, issue.Suppl 1, pp.223-236, 2006.
DOI : 10.4049/jimmunol.167.4.2323

G. P. Poggio, C. Rodriguez, D. Cisterna, M. C. Freire, and J. Cello, Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases, J Clin Microbiol, vol.38, pp.274-278, 2000.

S. H. Preskorn, Pharmacokinetics and Therapeutics of Acute Intramuscular Ziprasidone, Clinical Pharmacokinetics, vol.30, issue.6, pp.1117-1133, 2005.
DOI : 10.2165/00003088-200544110-00002

J. E. Preston, H. Sarraf, and M. B. Segal, Permeability of the developing blood-brain barrier to 14C-mannitol using the rat in situ brain perfusion technique, Developmental Brain Research, vol.87, issue.1, pp.69-76, 1995.
DOI : 10.1016/0165-3806(95)00060-Q

P. I. Rafailidis, E. G. Mourtzoukou, I. C. Varbobitis, and M. E. Falagas, Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review, Virology Journal, vol.5, issue.1, p.47, 2008.
DOI : 10.1186/1743-422X-5-47

R. A. Rajewski and V. J. Stella, Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery, Journal of Pharmaceutical Sciences, vol.85, issue.11, pp.1142-1169, 1996.
DOI : 10.1021/js960075u

Z. B. Redzic, I. D. Markovic, S. S. Jovanovic, J. M. Gasic, D. M. Mitrovic et al., Kinetics and sodium independence of [3H]-tiazofurin blood to brain transport in the guinea pig, Methods Find Exp Clin Pharmacol, vol.18, pp.413-418, 1996.

T. S. Reese and M. J. Karnovsky, FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE, The Journal of Cell Biology, vol.34, issue.1, pp.207-217, 1967.
DOI : 10.1083/jcb.34.1.207

O. Reichard, J. Andersson, R. Schvarcz, and O. Weiland, Ribavirin treatment for chronic hepatitis C, The Lancet, vol.337, issue.8749, pp.1058-1061, 1991.
DOI : 10.1016/0140-6736(91)91707-2

J. R. Romero and J. G. Newland, Viral meningitis and encephalitis: Traditional and emerging viral agents, Seminars in Pediatric Infectious Diseases, vol.14, issue.2, pp.72-82, 2003.
DOI : 10.1053/spid.2003.127223

F. Rozenberg, Diagnostic des infections virales neuro-méningées, pp.641-652, 2002.

R. R. Russell and J. C. Donald, Neurological Complications of Mumps, BMJ, vol.2, issue.5087, pp.27-30, 1958.
DOI : 10.1136/bmj.2.5087.27

M. Schleuning, H. Buxbaum-conradi, G. Jager, and H. J. Kolb, Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants, The Hematology Journal, vol.5, issue.2, 2004.
DOI : 10.1038/sj.thj.6200358

J. Schneider-schaulies, V. Meulen, and S. Schneider-schaulies, Measles Infection of the Central Nervous System, Journal of Neurovirology, vol.9, issue.2, pp.247-252, 2003.
DOI : 10.1080/13550280390193993

S. Schneider-schaulies and V. Ter-meulen, Modulation of immune functions by measles virus, Springer Seminars in Immunopathology, vol.24, issue.2, 2002.
DOI : 10.1007/s00281-002-0101-3

S. Schubert, K. Moller-ehrlich, K. Singethan, S. Wiese, W. P. Duprex et al., A mouse model of persistent brain infection with recombinant Measles virus, Journal of General Virology, vol.87, issue.7, pp.2011-2019, 2006.
DOI : 10.1099/vir.0.81838-0

L. J. Scott and C. M. Perry, Interferon-??-2b Plus Ribavirin, Drugs, vol.15, issue.4, pp.507-556, 2002.
DOI : 10.7326/0003-4819-127-10-199711150-00001

H. Shalev-zimels, Z. Weizman, C. Lotan, D. Gavish, Z. Ackerman et al., Extent of measles hepatitis in various ages, Hepatology, vol.316, issue.5, pp.1138-1139, 1988.
DOI : 10.7326/0003-4819-90-3-354

K. Shiotani, K. Uehata, T. Irie, F. Hirayama, and K. Uekama, Characterization of the Inclusion Mode of .BETA.-Cyclodextrin Sulfate and Its Effect on the Chlorpromazine-Induced Hemolysis of Rabbit Erythrocytes., CHEMICAL & PHARMACEUTICAL BULLETIN, vol.42, issue.11, pp.2332-2337, 1994.
DOI : 10.1248/cpb.42.2332

R. W. Sidwell, L. B. Allen, G. P. Khare, J. H. Huffman, J. T. Witkowski et al., Effect of 1-??-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Herpes and Vaccinia Keratitis and Encephalitis in Laboratory Animals, Antimicrobial Agents and Chemotherapy, vol.3, issue.2, pp.242-246, 1973.
DOI : 10.1128/AAC.3.2.242

N. J. Snell, Ribavirin Therapy for Nipah Virus Infection, Journal of Virology, vol.78, issue.18, 2004.
DOI : 10.1128/JVI.78.18.10211.2004

M. Sohler, Oligosymptomatic dengue infection: a potential cause of Guillain Barre syndrome, Arq Neuropsiquiatr, vol.66, pp.234-237, 2008.

T. Solomon, Recent Advances in Japanese Encephalitis, Journal of Neurovirology, vol.9, issue.2, pp.274-283, 2003.
DOI : 10.1080/13550280390194037

T. Solomon and M. Mallewa, Dengue and Other Emerging Flaviviruses, Journal of Infection, vol.42, issue.2, pp.104-115, 2001.
DOI : 10.1053/jinf.2001.0802

T. Solomon, M. H. Ooi, D. W. Beasley, and M. Mallewa, West Nile encephalitis, BMJ, vol.326, issue.7394, pp.865-869, 2003.
DOI : 10.1136/bmj.326.7394.865

R. Spiegel, D. Miron, H. Yodko, D. Lumelsky, A. Habib et al., Late Relapse of Herpes Simplex Virus Encephalitis in a Child Due to Reactivation of Latent Virus: Clinicopathological Report and Review, Journal of Child Neurology, vol.89, issue.3, pp.344-348, 2008.
DOI : 10.1007/s00415-005-0941-6

V. J. Stella and R. A. Rajewski, Cyclodextrins, Toxicologic Pathology, vol.5, issue.1, 1997.
DOI : 10.1023/A:1011041628797

V. J. Stella, V. M. Rao, E. A. Zannou, and V. V. Zia, Mechanisms of drug release from cyclodextrin complexes, Advanced Drug Delivery Reviews, vol.36, issue.1, pp.3-16, 1999.
DOI : 10.1016/S0169-409X(98)00052-0

E. L. Stephen, J. W. Dominik, J. B. Moe, and J. S. Walker, Therapeutic Effects of Ribavirin Given by the Intraperitoneal or Aerosol Route Against Influenza Virus Infections in Mice, Antimicrobial Agents and Chemotherapy, vol.10, issue.3, pp.549-554, 1976.
DOI : 10.1128/AAC.10.3.549

R. Stock, G. Harste, I. Madisch, and A. Heim, A rapid quantitative PCR-based assay for testing antiviral agents against human adenoviruses demonstrates type specific differences in ribavirin activity, Antiviral Research, vol.72, issue.1, pp.34-41, 2006.
DOI : 10.1016/j.antiviral.2006.03.009

M. Studahl, Influenza virus and CNS manifestations, Journal of Clinical Virology, vol.28, issue.3, pp.225-232, 2003.
DOI : 10.1016/S1386-6532(03)00119-7

L. L. Sweetman, Y. T. Ng, I. J. Butler, and J. B. Bodensteiner, Neurologic Complications Associated With Respiratory Syncytial Virus, Pediatric Neurology, vol.32, issue.5, pp.307-310, 2005.
DOI : 10.1016/j.pediatrneurol.2005.01.010

J. Szejtli and L. Szente, Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins, European Journal of Pharmaceutics and Biopharmaceutics, vol.61, issue.3, pp.115-125, 2005.
DOI : 10.1016/j.ejpb.2005.05.006

Y. Takasato, S. I. Rapoport, and Q. R. Smith, An in situ brain perfusion technique to study cerebrovascular transport in the rat, American Journal of Physiology-Heart and Circulatory Physiology, vol.247, issue.3, pp.484-493, 1984.
DOI : 10.1152/ajpheart.1984.247.3.H484

F. Tewes, J. Brillault, W. Couet, and J. C. Olivier, Formulation of rifampicin???cyclodextrin complexes for lung nebulization, Journal of Controlled Release, vol.129, issue.2, pp.93-99, 2008.
DOI : 10.1016/j.jconrel.2008.04.007

URL : https://hal.archives-ouvertes.fr/inserm-00319517

S. Tilloy, V. Monnaert, L. Fenart, H. Bricout, R. Cecchelli et al., Methylated ??-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood???brain barrier, Bioorganic & Medicinal Chemistry Letters, vol.16, issue.8, pp.2154-2157, 2006.
DOI : 10.1016/j.bmcl.2006.01.049

URL : https://hal.archives-ouvertes.fr/hal-00543357

A. R. Tunkel and W. M. Scheld, Acute Meningitis, Bennett & R. Dolin), vol.1, pp.959-997, 2000.
DOI : 10.1016/B978-0-443-06839-3.00084-9

K. Uekama and M. Otagiri, Cyclodextrin Drug Carrier Systems, Chemical Reviews, vol.98, issue.5, pp.1-40, 1987.
DOI : 10.1021/cr970025p

V. Uhlmann, C. M. Martin, O. Sheils, L. Pilkington, I. Silva et al., Potential viral pathogenic mechanism for new variant inflammatory bowel disease, Molecular Pathology, vol.55, issue.2, pp.84-90, 2002.
DOI : 10.1136/mp.55.2.84

URL : http://europepmc.org/articles/pmc1187154?pdf=render

J. P. Verheyden, Evolution of Therapy for Cytomegalovirus Infection, Clinical Infectious Diseases, vol.10, issue.Supplement_3, pp.477-489, 1988.
DOI : 10.1093/clinids/10.Supplement_3.S477

V. Von-messling, N. Svitek, and R. Cattaneo, Receptor (SLAM [CD150]) Recognition and the V Protein Sustain Swift Lymphocyte-Based Invasion of Mucosal Tissue and Lymphatic Organs by a Morbillivirus, Journal of Virology, vol.80, issue.12, pp.6084-6092, 2006.
DOI : 10.1128/JVI.00357-06

URL : https://hal.archives-ouvertes.fr/pasteur-00820002

M. Wasay, R. Channa, M. Jumani, G. Shabbir, M. Azeemuddin et al., Encephalitis and myelitis associated with dengue viral infection, Clinical Neurology and Neurosurgery, vol.110, issue.6, pp.635-640, 2008.
DOI : 10.1016/j.clineuro.2008.03.011

M. Wasay, R. Diaz-arrastia, R. A. Suss, S. Kojan, A. Haq et al., St Louis Encephalitis, Archives of Neurology, vol.57, issue.1, pp.114-118, 1995.
DOI : 10.1001/archneur.57.1.114

J. Watson, Prospects for hepatitis C virus therapeutics: levovirin and viramidine as improved derivatives of ribavirin, Curr Opin Investig Drugs, vol.3, pp.680-683, 2002.

S. Ganske, L. Manning, and M. Czub, Invasion of the central nervous system in a porcine host by nipah virus, J Virol, vol.79, pp.7528-7534, 2005.

T. F. Wild, Henipaviruses: A new family of emerging Paramyxoviruses, Pathologie Biologie, vol.57, issue.2, 2008.
DOI : 10.1016/j.patbio.2008.04.006

M. M. Williamson, P. T. Hooper, P. W. Selleck, H. A. Westbury, and R. F. Slocombe, A Guinea-pig Model of Hendra Virus Encephalitis, Journal of Comparative Pathology, vol.124, issue.4, pp.273-279, 2001.
DOI : 10.1053/jcpa.2001.0464

D. F. Willson, C. P. Landrigan, S. D. Horn, and R. J. Smout, Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia, The Journal of Pediatrics, vol.143, issue.5, pp.142-149, 2003.
DOI : 10.1067/S0022-3476(03)00514-6

K. T. Wong, I. Grosjean, C. Brisson, B. Blanquier, M. Fevre-montange et al., A Golden Hamster Model for Human Acute Nipah Virus Infection, The American Journal of Pathology, vol.163, issue.5, pp.2127-2137, 2003.
DOI : 10.1016/S0002-9440(10)63569-9

URL : https://hal.archives-ouvertes.fr/hal-00313149

P. J. Wright, G. Crameri, and B. T. Eaton, RNA synthesis during infection by Hendra virus: an examination by quantitative real-time PCR of RNA accumulation, the effect of ribavirin and the attenuation of transcription, Archives of Virology, vol.150, issue.3, pp.521-532, 2005.
DOI : 10.1007/s00705-004-0417-5

C. Wu, H. Qi, W. Chen, C. Huang, C. Su et al., Preparation and Evaluation of a Carbopol??/HPMC-based In Situ Gelling Ophthalmic System for Puerarin, YAKUGAKU ZASSHI, vol.127, issue.1, pp.183-191, 2007.
DOI : 10.1248/yakushi.127.183

J. Z. Wu, G. Larson, and Z. Hong, Dual-Action Mechanism of Viramidine Functioning as a Prodrug and as a Catabolic Inhibitor for Ribavirin, Antimicrobial Agents and Chemotherapy, vol.48, issue.10, pp.4006-4008, 2004.
DOI : 10.1128/AAC.48.10.4006-4008.2004

P. R. Wyde, D. K. Moore-poveda, E. De-clercq, J. Neyts, A. Matsuda et al., Use of Cotton Rats to Evaluate the Efficacy of Antivirals in Treatment of Measles Virus Infections, Antimicrobial Agents and Chemotherapy, vol.44, issue.5, pp.1146-1152, 2000.
DOI : 10.1128/AAC.44.5.1146-1152.2000

G. Wyshak and K. Detre, Estimating the number of organisms in quantal assays, 1972.

Y. Yanagi, M. Takeda, and S. Ohno, Measles virus: cellular receptors, tropism and pathogenesis, Journal of General Virology, vol.87, issue.10, pp.2767-2779, 2006.
DOI : 10.1099/vir.0.82221-0

URL : http://jgv.microbiologyresearch.org/deliver/fulltext/jgv/87/10/2767.pdf?itemId=/content/journal/jgv/10.1099/vir.0.82221-0&mimeType=pdf&isFastTrackArticle=

Y. Yanagi, M. Takeda, S. Ohno, and F. Seki, Measles virus receptors and tropism, Jpn J Infect Dis, vol.59, pp.1-5, 2006.
DOI : 10.1099/vir.0.82221-0

URL : http://jgv.microbiologyresearch.org/deliver/fulltext/jgv/87/10/2767.pdf?itemId=/content/journal/jgv/10.1099/vir.0.82221-0&mimeType=pdf&isFastTrackArticle=

J. Yang, C. J. Wiley, D. A. Godwin, and L. A. Felton, Influence of hydroxypropyl-??-cyclodextrin on transdermal penetration and photostability of avobenzone, European Journal of Pharmaceutics and Biopharmaceutics, vol.69, issue.2, pp.605-612, 2008.
DOI : 10.1016/j.ejpb.2007.12.015

M. Zhang and D. C. Rees, A review of recent applications of cyclodextrins for drug discovery, Expert Opinion on Therapeutic Patents, vol.9, issue.12, pp.1697-1717, 1999.
DOI : 10.1016/S0960-894X(99)00150-X